NYSEEnergyChemicalsSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for REX yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
CAPEX budget maintained between $220 million and $230 million in fiscal 2026 | A primary condition in REX American Resources Corporation's published investment case. The stated target is $220M-$230M. | Intact | CAPEX budget falls below $220 million or exceeds $230 million in FY26 | Capital expenditures: $23.338M FY2026-Q2; GAAP. Published target: $220M-$230M. Annual target cannot be compared with a quarterly or TTM observation. Sep 3, 202623,338,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Oct 6–Nov 4 · 0 recorded
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
REX is a cyclical energy-related business with an expansion-led growth angle, rather than a proven steady compounder. Its long-term thesis is intact, though confidence is medium and company quality has recently weakened.
REX is valued cheaply versus peers, and the evidence suggests current pricing is justified rather than reflecting an unusually severe mismatch. The expectations gap is negative, so the market appears to assume less than the valuation comparison alone might suggest.
Near-term results have been strong, including two recent earnings beats, and management is progressing with the ethanol expansion and carbon capture project. Earnings quality remains fragile, however, and the business operates in an industry with a history of misses; the latest risk assessment puts near-term miss risk in a quiet tier.
Over the next few quarters, completing the expansion and bringing it into full operation during fiscal 2026 are key execution tests. The thesis also depends on sector conditions: continued strong results from energy bellwethers could sustain a tailwind, while misses or lower guidance could weaken it; a guidance cut from REX would be a meaningful negative.
For a 1 to 3 year view, strong recent performance and project progress support an intact thesis, but fragile earnings quality and reliance on sector momentum remain important limits. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
earnings per share at or above $0.71 next quarter | REX keeps growing earnings with net income per share rising from $0.26 to $0.56 in one year. | Intact | EPS falls below $0.71 next quarter | Diluted EPS: $1.06 per share FY2027-Q2; GAAP. Published target: >= $0.71. Target period is not explicitly aligned with this observation. Sep 3, 20261.06 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
capital expenditures for One Earth Energy reach at least $176.3 million by Q2 2026 | A supporting condition in REX American Resources Corporation's published investment case. The stated target is >= $176.3 million. | Intact | capital expenditures for expansion fall below $176.3 million by Q2 2026 | Capital expenditures: $23.338M FY2026-Q2; GAAP. Published target: >= $176.3 million. Target period is not explicitly aligned with this observation. Sep 3, 202623,338,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 3 of 3 supplied quarters. Management reported: “The Company expects testing and commissioning to begin upon completion, with the expansion becoming operational during fiscal 2026.” “Capital expenditures to-date related to the One Earth Energy carbon capture and sequestration project and related expansion of ethanol production capacity at the Gibson City location totaled $191.2 million.” Delivery assessment Nov 4, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Dec 3, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.